Today, I met with my colleagues from the pharmaceutical industry to discuss how we, together, will negotiate the next pricing scheme for medicines in the NHS.
Ex-ABPI president Nigel Brooksby has recently written an article for 'Clinical Discovery' called 'Clinical Research - Innovation: Now is the right time to get it right for skills'
InPharm.com has featured an interview with our Chief Executive Stephen Whitehead.
Today we launched a series of ten key facts about how much the NHS spends on medicines (the medicines bill).
This year the ABPI has chosen to support Crisis, the national charity for homeless people, and the Science Media Centre, who work to promote more balanced and accurate coverage of science stories.
Today’s Times Education Supplement turns the spotlight on the teaching of science, technology, engineering and maths (STEM) and looks at how industry is working with schools to raise awareness and encourage more young people to follow career paths that use these skills.
Russell Brown’s letter to Andrew Lansley and Nicola Sturgeon calling for action to tackle medicines supply shortages is welcome. The Association of the British Pharmaceutical Industry has been calling for a solution too.
Following negotiations between the General Practitioners Committee (GPC) and NHS Employers (on behalf of the four health departments), agreement with the English, Scottish and Welsh departments on changes to the General Medical Services contract for 2011-12 has been reached.
The Daily Telegraph today published a front page story today accusing pharmaceutical manufacturers of rationing medicines. The article: 'Lives put at risk by shortage of drugs, NHS leaders warn' suggests that quotas are to blame for causing supply shortages in the NHS.
As debate on the pricing of medicines in the UK continues, here I address some of the latest thinking on the subject.
The problem of counterfeit medicines has always been a concern. Bona fide medicines quite rightly go through rigorous testing every step of the way to ensure that patient safety is protected. And the supply chain from manufacturers through to wholesalers, pharmacists, and doctors is a carefully...